CIBC World Market’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-12,585
Closed -$411K 1352
2021
Q4
$411K Sell
12,585
-2,645
-17% -$106K ﹤0.01% 1040
2021
Q3
$625K Buy
15,230
+50
+0.3% +$1.81K ﹤0.01% 907
2021
Q2
$547K Buy
15,180
+3,035
+25% +$112K ﹤0.01% 961
2021
Q1
$474K Buy
12,145
+2,545
+27% +$114K ﹤0.01% 978
2020
Q4
$387K Buy
+9,600
New +$441K ﹤0.01% 1015

Other funds holding GDRX

CIBC World Market's GDRX Position: Q1 2022 in Review

CIBC World Market sold out of GoodRx Holdings (GDRX) in Q1 2022, closing a stake of 12,585 shares — an estimated $411K sold.

CIBC World Market first reported a position in GDRX in Q4 2020 and held it in 5 quarters. The position peaked at $625K in Q3 2021. 167 funds tracked by Wall St. Rank hold GDRX as of Q1 2022.

  • CIBC World Market reported no remaining GoodRx Holdings position as of Q1 2022 after selling out during the quarter.
  • CIBC World Market sold 12,585 GoodRx Holdings shares in Q1 2022, an estimated $411K.
  • CIBC World Market first reported a position in GoodRx Holdings in Q4 2020 and held it in 5 quarters.
  • CIBC World Market's GoodRx Holdings position peaked at $625K in Q3 2021.
  • 167 funds tracked by Wall St. Rank held GoodRx Holdings as of Q1 2022.

Based on CIBC World Market's 13F filing for Q1 2022, filed 12 May 2022.